Home » All » Stock Forecast » CytomX Therapeutics Inc. Common Stock Forecast

CytomX Therapeutics Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC
▼ -2.66%Market Cap $810.09M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

TimeframePredicted PricePastHistoricalInsight
Tomorrow$4.81 ▲ +1.15%Yesterday$4.74 ▼ -0.48%Tomorrow's CytomX Therapeutics Inc. Common Stock (CTMX) setup is anchored to $4.76 and targets $4.81 (+1.15%). The near-term read is upside; watch $4.90 / $4.62 because daily realized volatility is about 5.93%.
Tomorrow's CytomX Therapeutics Inc. Common Stock (CTMX) setup is anchored to $4.76 and targets $4.81 (+1.15%). The near-term read is upside; watch $4.90 / $4.62 because daily realized volatility is about 5.93%.
Week$4.93 ▲ +3.58%Last Week$4.69 ▼ -1.50%The 7-day CytomX Therapeutics Inc. Common Stock model moves from $4.69 to $4.93 (+3.58%). It gives upside momentum context for this stock, so breaks around $4.90 / $4.62 matter more than a single tick.
The 7-day CytomX Therapeutics Inc. Common Stock model moves from $4.69 to $4.93 (+3.58%). It gives upside momentum context for this stock, so breaks around $4.90 / $4.62 matter more than a single tick.
Month$5.12 ▲ +7.61%Last Month$4.61 ▼ -3.20%The 1-month CytomX Therapeutics Inc. Common Stock target is $5.12 (+7.61%), compared with the live reference near $4.76. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month CytomX Therapeutics Inc. Common Stock target is $5.12 (+7.61%), compared with the live reference near $4.76. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$5.41 ▲ +13.67%Last Year$4.49 ▼ -5.74%The 1-year CytomX Therapeutics Inc. Common Stock scenario points to $5.41 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year CytomX Therapeutics Inc. Common Stock scenario points to $5.41 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$6.09 ▲ +27.86%5 Years Ago$4.20 ▼ -11.70%The 5-year CytomX Therapeutics Inc. Common Stock view is $6.09 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year CytomX Therapeutics Inc. Common Stock view is $6.09 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Tomorrow$4.81▲ +1.15%
Yesterday$4.74▼ -0.48%
Tomorrow's CytomX Therapeutics Inc. Common Stock (CTMX) setup is anchored to $4.76 and targets $4.81 (+1.15%). The near-term read is upside; watch $4.90 / $4.62 because daily realized volatility is about 5.93%.
Week$4.93▲ +3.58%
Last Week$4.69▼ -1.50%
The 7-day CytomX Therapeutics Inc. Common Stock model moves from $4.69 to $4.93 (+3.58%). It gives upside momentum context for this stock, so breaks around $4.90 / $4.62 matter more than a single tick.
Month$5.12▲ +7.61%
Last Month$4.61▼ -3.20%
The 1-month CytomX Therapeutics Inc. Common Stock target is $5.12 (+7.61%), compared with the live reference near $4.76. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$5.41▲ +13.67%
Last Year$4.49▼ -5.74%
The 1-year CytomX Therapeutics Inc. Common Stock scenario points to $5.41 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$6.09▲ +27.86%
5 Years Ago$4.20▼ -11.70%
The 5-year CytomX Therapeutics Inc. Common Stock view is $6.09 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish
$5.03$4.92$4.82$4.71$4.601W AgoNow7D F

Technical Analysis

SellNeutralBuy
Neutral
1
Bullish
3
Neutral
1
Bearish

Key Indicators

IndicatorValueSignal
Price$4.76 Mid
Daily Change-2.66% Below
Volatility Cap20.0% Mid
Confidence63% Above
Data Sourcenasdaq-screener Mid

Historical Data

Current$4.76
Daily Change-2.66%
Market Cap$810.09M
Sourcenasdaq-screener
Current$4.76Daily Change-2.66%
Market Cap$810.09MSourcenasdaq-screener

Support & Resistance Levels

$4.62Support 1
$4.76Current
$4.90Resistance 1
i
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context
Current$4.76Live reference price
Used as the anchor for generated forecast calculations.
Next Month$5.12Model projection+7.61%
Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed
63%
Directional
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.
Short term
63%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in CTMX today
Bullish Scenario
$5.00
+5.00% from current
Target Price$5.00
ScenarioUpside momentum
Probability55%
Base Scenario
$5.12
+7.61%
Target Price$5.12
ScenarioCapped drift
Probability63%
Bearish Scenario
$4.52
-5.00% from current
Target Price$4.52
ScenarioVolatility drawdown
Probability37%
Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 66/100
24H drift+1.15%
7D drift+3.58%
30D drift+7.61%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 64/100
1M outlook+7.61%
1Y outlook+13.67%
5Y outlook+27.86%

Frequently Asked Questions

Q What is the CytomX Therapeutics Inc. Common Stock (CTMX) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), CytomX Therapeutics Inc. Common Stock is projected near $4.81 versus the current reference around $4.76. That implies a modeled move of +1.15% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for CTMX?
The weekly CytomX Therapeutics Inc. Common Stock model points to $4.93, which maps to an expected drift of +3.58% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the CytomX Therapeutics Inc. Common Stock 1-month and 1-year targets?
The CytomX Therapeutics Inc. Common Stock 1-month target is $5.12 (+7.61%), while the 1-year target is $5.41 (+13.67%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the CytomX Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?
The CytomX Therapeutics Inc. Common Stock long-horizon scenario sits near $6.09 with a modeled change of +27.86%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are CTMX support and resistance zones right now?
For CytomX Therapeutics Inc. Common Stock, nearest resistance is around $4.62, while nearest support is around $4.90. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the CytomX Therapeutics Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.

Recommended Forecasts

Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.

Stronger Bullish Ideas

Tomorrow
CaterpillarCAT+3.80%$774.20ArmARM+3.79%$125.28TSMCTSM+3.78%$366.36
7 Days
DeereDE+9.49%$602.92T-MobileTMUS+9.48%$219.50AbbVieABBV+9.26%$231.50
1 Month
Exxon MobilXOM+18.72%$148.45ASMLASML+18.58%$1,406.61Lowe'sLOW+18.30%$287.39
1 Year
WalmartWMT+22.82%$133.89Johnson & JohnsonJNJ+22.61%$243.45AlphabetGOOGL+19.93%$305.72
5 Years
Coca-ColaKO+30.55%$78.68Eli LillyLLY+27.81%$1,040.00CostcoCOST+26.34%$1,018.48

Weaker Bearish Ideas

Tomorrow
NikeNKE-3.33%$63.13DisneyDIS-2.75%$105.45AirbnbABNB-2.28%$121.35
7 Days
ModernaMRNA-5.99%$42.23SalesforceCRM-5.28%$189.72AlibabaBABA-4.64%$155.73
1 Month
SnowflakeSNOW-11.54%$182.29PfizerPFE-10.04%$27.58UnitedHealthUNH-9.45%$293.19
1 Year
OracleORCL-16.74%$160.14NetflixNFLX-16.29%$76.87UberUBER-15.44%$69.99
5 Years
LyftLYFT-37.99%$13.27IntuitINTU-36.83%$399.40AdobeADBE-33.03%$263.97
Cytom X Therapeutics Inc. Common Stock Forecast 2026 – Tomorrow, Week & Month